SWAV | ShockWave Medical, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	334.75 - 334.90
52 Week Range	157.00 - 334.90
Beta	1.12
Implied Volatility	45.46%
IV Rank	0.14%
Day's Volume	3,947,054
Average Volume	1,246,461
Shares Outstanding	37,543,500
Market Cap	12,567,686,625
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2019-03-07

Valuation
Profitability
Growth
Health
P/E Ratio	78.76
Forward P/E Ratio	68.44
EPS	4.25
1YR Price Target	255.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	1,468
Country	USA
Website	SWAV

ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.

SWAV's peers: ALGN, BFLY, BIO, CLPT, DXCM, INMD, INOV, INSP, MASI, NARI, NNOX, NVCR, OM, PEN, PODD, QDEL, TMDX, TNDM

*Chart delayed

Analyzing fundamentals for SWAV we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is wealthy, Growth is exceptionally good and Health is strong. For more detailed analysis please see SWAV Fundamentals page.

Watching at SWAV technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on SWAV Technicals page.